Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $98.36 USD
Change Today +1.36 / 1.40%
Volume 131.4K
As of 8:10 PM 06/1/15 All times are local (Market data is delayed by at least 15 minutes).

icu medical inc (ICUI) Snapshot

Open
$97.75
Previous Close
$97.00
Day High
$98.95
Day Low
$96.45
52 Week High
06/1/15 - $98.95
52 Week Low
08/8/14 - $56.62
Market Cap
1.6B
Average Volume 10 Days
122.5K
EPS TTM
$2.50
Shares Outstanding
15.8M
EX-Date
--
P/E TM
39.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for ICU MEDICAL INC (ICUI)

icu medical inc (ICUI) Related Businessweek News

No Related Businessweek News Found

icu medical inc (ICUI) Details

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, oncology, and critical care applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient’s vein for use in hospitals and ambulatory clinics. The company’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave clear, anti-microbial MicroClave, neutrons, NanoClave, and Clave; custom infusion sets; and Tego needlefree hemodialysis connectors. It also provides critical care products used to monitor signs, as well as physiological functions of organ systems. The company’s critical care products comprises hemodynamic monitoring systems, including Transpac disposable pressure transducers, Safeset closed needlefree blood conservation systems, and custom monitoring systems; sensor, pulmonary artery thermodilution, central venous oximetry, and multi-lumen central venous catheters; custom angiography and interventional radiology kits; and Lopez enteral valves. In addition, it offers a line of oncology products that are used to prepare and deliver hazardous medications used in chemotherapy, such as ChemoLock and ChemoClave closed system transfer device and components, and Diana hazardous drug compounding system. The company sells its products to medical product manufacturers, independent distributors, and directly to end users. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

2,280 Employees
Last Reported Date: 02/20/15
Founded in 1984

icu medical inc (ICUI) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $574.2K
Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $395.2K
Vice President of Operations
Total Annual Compensation: $390.5K
Vice President and General Manager of Critica...
Total Annual Compensation: $333.6K
Vice President and General Manager of Infusio...
Total Annual Compensation: $315.0K
Compensation as of Fiscal Year 2014.

icu medical inc (ICUI) Key Developments

ICU Medical, Inc. Announces Directors Retirement

The Board of Directors of ICU Medical, Inc. adopted a director retirement policy pursuant to which no person may stand for election following his or her 76th birthday and each serving director must resign upon his or her 76th birthday. The policy also requires that as a condition for the nomination of any director who would reach the age of 76 before the end of his or her term, he or she must submit an advance irrevocable resignation that becomes effective on the director's 76th birthday. In accordance with this policy, on April 30, 2015, directors Jack W. Brown and John J. Connors, Esq. delivered letters to the company's Board of Directors tendering their resignations effective as of their respective 76th birthdays, December 13, 2015 and November 21, 2015.

ICU Medical, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

ICU Medical, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, net sales were $81.323 million against $73.113 million a year ago. Total revenue was $81.484 million against $73.230 million a year ago. Income from operations was $10.973 million against $9.877 million a year ago. Income before income taxes was $11.499 million against $10.087 million a year ago. Net income was $9.686 million or $0.60 per diluted share against $6.657 million or $0.43 per diluted share a year ago. Net cash provided by operating activities was $13.251 million against $12.714 million a year ago. Purchases of property and equipment were $2.357 million against $5.908 million a year ago. Intangible asset additions were $0.208 million against $0.120 million a year ago. Adjusted EBITDA was $26.000 million against $16.825 million a year ago. Adjusted diluted earnings per share were $1.02 against $0.54 a year ago. The increase in adjusted EPS was due to strong top line growth, improved gross margin, decreased SG&A expenses and lower tax expense. First quarter adjusted EBITDA increased 55% to $26 million compared to $17 million last year. This increase was due to the same drivers except for tax.

ICU Medical, Inc. to Report Q1, 2015 Results on May 05, 2015

ICU Medical, Inc. announced that they will report Q1, 2015 results at 4:00 PM, Eastern Daylight on May 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICUI:US $98.36 USD +1.36

ICUI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AngioDynamics Inc $16.11 USD +0.06
Cyberonics Inc $65.40 USD +1.39
NxStage Medical Inc $16.02 USD -0.19
Orthofix International NV $32.61 USD -0.16
Wright Medical Group Inc $27.51 USD +0.11
View Industry Companies
 

Industry Analysis

ICUI

Industry Average

Valuation ICUI Industry Range
Price/Earnings 52.4x
Price/Sales 4.8x
Price/Book 3.0x
Price/Cash Flow 52.1x
TEV/Sales 3.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICU MEDICAL INC, please visit www.icumed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.